Additionally, lncRNA MALAT-1 inhibits the expression of the epithelial marker E-cadherin in bladder cancer cells by targeting the miR-124/foxq1 axis and acting as a downstream mediator of TGF-β with the suppressor of zeste 12 (suz12), while increasing the expression of the mesenchymal markers N-cadherin and fibronectin, thereby promoting the bladder cancer cells’ EMT (Table A1) [74,75]. Here, CDH2 is linked to urinary bladder carcinoma.